Retinal Dysfunction in Alzheimer's Disease and Implications for Biomarkers

Area of Science:

• Neuroscience
• Ophthalmology
• Biomarker Research

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing cognitive decline.
• The retina shares anatomical and neurological similarities with the brain, suggesting a link to AD progression.
• Early detection of AD is crucial for managing the disease's impact.

Purpose of the Study:

• To review evidence of early-stage retinal dysfunction in Alzheimer's disease.
• To explore the molecular mechanisms underlying retinal changes in AD.
• To compare retinal pathologies in AD with other eye diseases and identify potential biomarkers.

Main Methods:

• Literature review of studies on Alzheimer's disease and retinal changes.
• Analysis of molecular mechanisms implicated in AD-related retinal dysfunction.
• Comparative analysis of retinal pathologies and biomarker potential.

Main Results:

• Evidence suggests early-stage retinal dysfunction occurs in Alzheimer's disease.
• Specific molecular pathways are associated with AD-induced retinal pathologies.
• Retinal biomarkers show potential for early AD detection and monitoring.

Conclusions:

• The retina serves as a potential window for understanding and diagnosing Alzheimer's disease.
• Further research into retinal biomarkers could lead to novel diagnostic tools for early AD detection.
• Understanding retinal changes offers insights into neurodegenerative processes common to AD.